©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 7, 2015; 21(37): 10636-10643
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10636
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10636
Resveratrol: A potential challenger against gastric cancer
Aida Zulueta, Anna Caretti, Paola Signorelli, Riccardo Ghidoni, Department of Health Sciences, San Paolo Hospital, University of Milan, 20142 Milano, Italy
Author contributions: All authors contributed to the manuscript preparation and revision.
Conflict-of-interest statement: The authors declare no conflict of interest.
Correspondence to: Riccardo Ghidoni, PhD, Department of Health Sciences, San Paolo Hospital, University of Milan, via Antonio di Rudinì 8, 20142 Milano, Italy. riccardo.ghidoni@unimi.it
Telephone: +39-250-323250 Fax: +39-250-323245
Received: May 18, 2015
Peer-review started: May 20, 2015
First decision: June 23, 2015
Revised: July 9, 2015
Accepted: August 31, 2015
Article in press: August 31, 2015
Published online: October 7, 2015
Processing time: 132 Days and 18.2 Hours
Peer-review started: May 20, 2015
First decision: June 23, 2015
Revised: July 9, 2015
Accepted: August 31, 2015
Article in press: August 31, 2015
Published online: October 7, 2015
Processing time: 132 Days and 18.2 Hours
Core Tip
Core tip: Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer-related mortality in the world. Despite the improvement of conventional therapies for advanced GC, the length or quality of life of patients with advanced GC is still poor. Resveratrol exerts bactericidal activity against Helicobacter pylori, acting as a GC preventive agent. Resveratrol therapeutic potential against GC initiation and progression is thus required to be surveyed and this is done within this minireview.